Full Text View
Tabular View
No Study Results Posted
Related Studies
Diagnosis of Hemangiomas and Vascular Malformations
This study is enrolling participants by invitation only.
Study NCT00577213   Information provided by University of Arkansas
First Received: December 18, 2007   Last Updated: June 17, 2009   History of Changes

December 18, 2007
June 17, 2009
February 2007
 
 
 
Complete list of historical versions of study NCT00577213 on ClinicalTrials.gov Archive Site
 
 
 
Diagnosis of Hemangiomas and Vascular Malformations
Diagnosis of Hemangiomas and Vascular Malformations Using Non-Invasive Imaging Devices

To develop a non-invasive, simple and affordable, measurement technique to differentiate hemangiomas from subtypes of VMS. The purpose of this study is to determine the best office based diagnositc instrument for differentiating the subtype of vascular lesions. The instrument must be simple and affordable so it can be used by primary car physicians in the doctor office. The procedure will be based on non-invasive and unharmful measurements that will be compared to the diagnosis from specialized physicians in this field and the final pathology.

 
 
Observational
Cohort, Cross-Sectional
  • Hemangiomas
  • Vascular Malformations
  • Venular Malformations
  • Venous Malformations
  • Lymphatic Malformations
  • Arteriovenous Malformations
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Enrolling by invitation
55
September 2010
 

Inclusion Criteria:

  • Suspected Hemangioma, Vascular Malformations (VMS) including venular Malformations (port-wine stain, PWS), Venous Malformations, Lymphatic Malformations, Arteriovenous Malformations or mixed malformations.

Exclusion Criteria:

  • All pregnant individuals will be excluded, since physiologic changes of pregnancy could alter characteristics of the vascular lesion.
Both
up to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00577213
Dr. Gal Shafirstein, University of Arkansas, Arkansas Children's Hospital
47573, Chancellor's Fund
University of Arkansas
 
Principal Investigator: Gal Shafirstein, Ph.D. UAMS, ACH, Central Arkansas Veterans Healthcare System
Study Director: Jessica L Blackwell UAMS, ACH, Central Arkansas Veterans Healthcare System
University of Arkansas
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP